University of California at San Francisco (UCSF)

University of California San Francisco

Dr. Beljanski showed that the active compounds in his Pao pereira extract do cross the blood brain barrier and so may exert their anti-tumor effect on brain cancers, including glioblastoma.

The Beljanski Foundation is now sponsoring a new research program focused on providing an improved treatment. The Beljanski Foundation is collaborating with researchers at the University of California at San Francisco (UCSF) to study the effectiveness of a plant extract, Pao pereira, that has been shown to have a broad spectrum of anti-cancer activity. The French scientist Mirko Beljanski, PhD, at the Pasteur Institute in Paris, developed this extract.

 

Health Media Group

Health media groupHealth Media Group is a wellness-marketing organization, specializing in positioning Anti-Aging, Integrative and wellness oriented physicians, healers and companies in front of the New York public.

Through our events, publications, advertising, publicity, videos, and media partnerships, they create a platform that helps familiarize and educate the millions of people reach with the philosophy of the leading cast members of this, (as per an American economist Paul Zane Pilzer), the next trillion dollar industry.

Demos Medical Publishing

Demos-Medical

Over the last 25 years, Demos Medical Publishing has gained an international reputation as one of the last independent providers of high quality professional books and other scholarly resources for physicians and healthcare professionals. Demos Medical Publishing is also very committed to the mission of bridging the gap between consumers and the healthcare community and has been working tirelessly to promote the open spread of scientific knowledge in an accessible manner.

Mirko Beljanski’s book “The Regulation of DNA Transcription and Replication”, originally published in 1983 by the prestigious scientific publisher Karger, is available both in an e-book and printed format. These two will be the first part of an upcoming series of classical monographs of scientific importance, which remain of interest to the scholarly community.

Natural Source International, Ltd.

Natural Source International

Thanks to Natural Source International, Ltd., the exclusive manufacturer of the Beljanski® products (Pao V®, Pao V “FM”®, Prostabel®, Rovol V®, Ginkgo V® and RealBuild®), the Beljanski Foundation was provided with quality extracts (Pao pereira, Rauwolfia vomitoria, Golden leaf of Ginkgo Biloba, ARN fragments) that has allowed us to perform outstanding research with prestigious scientific partners such as Columbia University, Kansas University Medical CenterUniversity of California, Nanjing University.

 

 

 

CIRIS

ciris-logoLed by Mrs. Pierrette Weidlich, CIRIS, whose activities are located mainly in Europe, works closely with The Beljanski Foundation and sponsors research with products that stem from Mirko Beljanski’s research.

Learn more about the CIRIS

Nanjing University

Nanjing_UniversityNanjing University (NJU or NU, simplified Chinese: 南京大学; traditional Chinese: 南京大學; pinyin: Nánjīng Dàxué; colloquially 南大, Nándà), or Nanking University, is one of the oldest and most prestigious institutions of higher learning in China.
Dr. Jun Yan from Dr. Aaron Katz’s laboratory at Columbia University Medical Center is continuing research (University of Nanjing, China) on the anti-cancer and anti-inflammatory activities of Pao Pereira (extract provided by Natural Source International, Ltd.).

The publication shows that this Pao pereira extract is effective against prostate cancer cells that no longer respond to agents that interfere with hormone action.

Publication:
Pao pereira Extract Suppresses Castration- Resistant Prostate Cancer Cell Growth, Survival and Invasion Through Inhibition of NFkB Signaling

by Cunjie Chang, BS, Wei Zhao, MS, Bingxian Xie, BS, Yongming Deng, BS, Tao Han, BM, Yangyan Cui, BS, Yundong Dai, BS, Zhen Zhang, BS, Jimin Gao, MD, PhD, Hongqian Guo, MD, PhD, and Jun Yan, PhD. Integrative Cancer Therapies 2013, Vol XX(X) 1–10.

Kansas University Medical Center

Kansas universityKansas University Medical Center confirmed with in vitro and in vivo studies, that both Pao pereira and Rauwolfia vomitoria (extract provided by Natural Source International, Ltd.) were active against pancreatic and ovarian cancers and showed excellent synergistic action with gemcitabine and carboplatine chemotherapies.

Publications on Ovarian Cancer:
The plant extract of Pao pereira potentiates carboplatin effects against ovarian cancer” Jun Yu and Qi Chen, Pharmaceutical biology, DOI: 10.3109/13880209.2013.808232

Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer Jun Yu, PhD, Yan Ma, PhD, Jeanne Drisko, MD, Qi Chen, PhD Current Therapeutic Research 75 (2013) 8–14

Publications on Pancreatic Cancer:
Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira” in the Oncology Reports Journal (vol.30 No. 1, pp. 149-156, 2009 – doi: 10.3892/or.2013.2461).

Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer” Jun Yu, PhD and Qi Chen, PhD

Columbia University

Columbia UniversityAt Columbia University the plants extracts Rauwolfia vomitoria and Pao pereira (extracts provided by Natural Source International, Ltd.) were tested for their anti-cancer properties, and a dose escalation trial confirmed that most patients tolerated the extracts safely, saw their PSA decrease and urinary symptoms improve.

Publications:
Anti-prostate cancer activity of B-carboline alkaloid enriched extract from Rauwolfia vomitoria” by D.L. Bemis, J.L. Capodice, P. Gorroochurn, A.E. Katz and R. Buttyan, International Journal of Oncology 29: 1065-1073, 2006

B-Carboline Alkaloid-Enriched Extract from the Amazonian Rain Forest Tree Pao Pereira Suppresses Prostate Cancer Cells” by Debra L. Bemis, PhD, Jillian L. Capodice, LAc, MS, Manisha Desai, PhD, Aaron E. Katz, MD, Ralph Buttyan, PhD, Journal of the Society for Integrative Oncology, Vol 7, No 2 (Spring), 2009

Cancer Treatment Centers of America

Cancer Treatment Center of America

The Beljanski Foundation has been able to test short RNA-fragments (extracts provided by Natural Source International, Ltd.) in a clinical trial conducted with cancer patients undergoing chemotherapy at Cancer Treatment Center of America ®  (CTCA). These studies have confirmed the ability of those fragments to support a normal level of platelets.

Publication:
Dose escalation study of an antithrombacytopenic agent in patients with chemotherapy induced thrombocytopenia” by Robert D Levin, MaryAnn Daehler, James F Grutsch, John L Hall, Digant Gupta, Christopher G Lis. Levin, Online magazine Bio Med Central BMC Cancer10:565 – 2010